Combining FDG-PET and 11C-2β-carbomethoxy-3β-(4-fluorophenyl) tropane (CFT), cerebral metabolism and dopaminergic neuronal activity were assessed in N = 6 GBA1 mutation carriers with and without Parkinsonism [55]. The gene discussed is GBA1; the disease is Parkinsonism.